Clinical Trial Update: DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating DDAVP to reduce postoperative ecchymosis in rhinoplasty was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ecchymosis
• Rhinoplasty

Drugs mentioned

• DDAVP (desmopressin acetate)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Postoperative Ecchymosis | Phase 2 | Status: TERMINATED | Results posted: 2023-08-16